Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Vivus Inc Selects Michael Astrue As Chairman And Tony Zook As Chief Executive Officer


Monday, 22 Jul 2013 09:41pm EDT 

Vivus Inc announced that Board of Directors has appointed Michael Astrue to serve as Chairman and Anthony Zook to serve as Chief Executive Officer, effective from July 22, 2013. Mr. Astrue formerly served as Chief Executive Officer of Transkaryotic Therapies, Chairman of the Massachusetts Biotechnology Council, and Commissioner of Social Security. Mr. Zook formerly served as Executive Vice President, Global Commercial Operations for AstraZeneca and President of Medimmune.